This new Notice of Funding Opportunity (NOFO) for Medication Assisted Recovery Mobile Health Units 3.0 (MMHU-3) sets forth the requirements for applications to improve the health and safety of individuals with opioid use disorder (OUD) and other substance use disorders (SUDs) who are considered at high risk for overdose and medical complications due to barriers to health care access.
This goal of MMHU-3 is to be achieved through the following objectives:
Increase access to medication assisted recovery (MAR) for individuals with OUD or other SUDs.
Decrease health inequities by making immediate care of acute and chronic conditions, including OUD/SUD, available to individuals within the priority population wherever care is sought in the service area.
To accomplish these objectives, subrecipients of MMHU-3 funding will:
Provide care for acute and chronic conditions, including U.S. Food and Drug Administration (FDA)-approved OUD medications, via mobile health units in the communities where the intended recipients live.
Manage and support transitions to additional recovery services among individuals within the priority population.
Promote the availability of mobile health units within the service area.
Up to three organizations will be awarded funds to fulfill the requirements of the subaward.
MMHU-3 NOFO
This new Notice of Funding Opportunity (NOFO) for Medication Assisted Recovery Mobile Health Units 3.0 (MMHU-3) sets forth the requirements for applications to improve the health and safety of individuals with opioid use disorder (OUD) and other substance use disorders (SUDs) who are considered at high risk for overdose and medical complications due to barriers to health care access.
This goal of MMHU-3 is to be achieved through the following objectives:
Increase access to medication assisted recovery (MAR) for individuals with OUD or other SUDs.
Decrease health inequities by making immediate care of acute and chronic conditions, including OUD/SUD, available to individuals within the priority population wherever care is sought in the service area.
To accomplish these objectives, subrecipients of MMHU-3 funding will:
Provide care for acute and chronic conditions, including U.S. Food and Drug Administration (FDA)-approved OUD medications, via mobile health units in the communities where the intended recipients live.
Manage and support transitions to additional recovery services among individuals within the priority population.
Promote the availability of mobile health units within the service area.
Up to three organizations will be awarded funds to fulfill the requirements of the subaward.